Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.8%

169 terminated/withdrawn out of 2901 trials

Success Rate

92.5%

+6.0% vs industry average

Late-Stage Pipeline

8%

236 trials in Phase 3/4

Results Transparency

43%

897 of 2095 completed trials have results

Key Signals

330 recruiting897 with results96 terminated73 withdrawn

Enrollment Performance

Analytics

N/A
1283(49.0%)
Phase 2
563(21.5%)
Phase 1
444(17.0%)
Phase 4
121(4.6%)
Phase 3
115(4.4%)
Early Phase 1
91(3.5%)
2617Total
N/A(1283)
Phase 2(563)
Phase 1(444)
Phase 4(121)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (2901)

Showing 20 of 2901 trials
NCT07421102Early Phase 1Recruiting

Pilot of Mailing Buprenorphine

Role: collaborator

NCT07737912Not ApplicableEnrolling By Invitation

SpinePal Open Pilot

Role: collaborator

NCT06860607Phase 1Recruiting

Environment and Alcohol: A Pilot Study

Role: lead

NCT06868914Phase 1Not Yet Recruiting

Phase I Trial of High-Density Theta Burst Stimulation (hdTBS)

Role: lead

NCT07637669Not Yet Recruiting

Olfactory Function and Model-Based Behavior in People Living With HIV and SUD

Role: lead

NCT07099092Early Phase 1Not Yet Recruiting

Causal Mechanisms of Odor-Guided Behavior in Humans

Role: lead

NCT05589181Phase 3Recruiting

High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)

Role: collaborator

NCT06676059Recruiting

SMART-r: Substance Monitoring and Active Relapse Tracking Repository

Role: lead

NCT06995885Enrolling By Invitation

Development of an Interview-Informed Timeline Follow-Back (TLFB) for Opioid Use in the Era of Fentanyl

Role: lead

NCT06577454Not ApplicableSuspended

Measuring the Effects of Neurostimulation on Risky and Ambiguous Decision-Making Capacity in People With and Without Substance Use Disorder

Role: lead

NCT06561828Early Phase 1Recruiting

Developing Transcranial Neuromodulation Protocols for Learning and Decision-Making

Role: lead

NCT04935606Not ApplicableCompleted

mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care

Role: collaborator

NCT07064564Phase 1Recruiting

iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers

Role: collaborator

NCT07549126Not ApplicableCompleted

Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 1

Role: collaborator

NCT05657106Not ApplicableActive Not Recruiting

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

Role: collaborator

NCT06523985Not ApplicableActive Not Recruiting

The Feasibility of Using the PulsePoint to Facilitate Overdose Education and Naloxone Distribution

Role: collaborator

NCT07734727Not ApplicableNot Yet Recruiting

Adaptation and Testing of a Novel Text-based Tobacco Cessation and Education Intervention in Kenyan Emergency Department Patients

Role: collaborator

NCT06875323Not ApplicableEnrolling By Invitation

FostrSpace-CASA R61/R33

Role: collaborator

NCT06679751Active Not Recruiting

Infectious Disease (ID) Testing OUtreach in Carceral Hubs

Role: collaborator

NCT00787423Completed

Developing Field Tools for Real-Time Assessment of Exposure to Psychosocial Stress and Drug Use in an Outpatient Treatment Population

Role: lead